ArriVent BioPharma Inc

AVBP NASDAQ Santé & Biotech États-Unis US04272N1028
30.20 $
0.95 %

ArriVent BioPharma se concentre sur le développement de produits biopharmaceutiques avancés pour diverses thérapies, notamment en oncologie.

Performance & Momentum

6 Months 23.67 %
1 Year 27.80 %
3 Years 51.00 %
5 Years 51.00 %

Similar stocks to ArriVent BioPharma Inc

Anantys Community

Be the first to share your analysis on ArriVent BioPharma Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases